Project Grant HT94252510901
Award Date 10/1/25
Completion Date 9/30/27
Dollars Obligated $130K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New Zealand
Similar Awards
- The Department of the Army Medical Command awarded a $1,126,472 project grant under the Military Medical Research and Development (CFDA 12.420) program to The University of Auckland in New Zealand. The purpose of the grant is to identify the earliest druggable targets for Parkinson's disease. The award has a performance period from September 1, 2024 to August 31, 2027. As a prominent international research institution, The University of Auckland has established a strong track record of...
- The University of Auckland in New Zealand was awarded a $534,258 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research applying enhanced electroceutical treatments and identifying electrical biomarkers for spinal cord injury from September 1, 2023 through August 31, 2026. As part of its mission to transform military and public health through innovative medical research solutions, the Defense Health...
- This $1,155,000.00 federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), supports the Regents of the University of Minnesota in evaluating prostate cancer patient natural killer cell function across racial backgrounds and addressing functional disparities with trispecific killer engagers. The award period runs from June 1, 2025 to May 31, 2029. This research aims to transform healthcare for military service members,...
- The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....
- This federal Project Grant award of $563,707.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research by the University of Queensland in Australia. The research aims to predict early-stage melanoma at high risk of recurrence through multiomics profiling. The project will leverage the university's expertise in biomedical research, oncology, and innovative scientific approaches to transform healthcare for military...
- This Project Grant award, valued at $2,000,000.00 and running from June 1, 2025 to May 31, 2028, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding supports advanced biomedical research at the University of Nebraska Medical Center (UNMC) aimed at investigating the interrelationship between the PINK1-PRKN pathway disruption and tauopathy in the pathophysiology of cognitive impairment in Parkinson's...
- This federal Project Grant award in the amount of $1,844,306.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the award will fund research by the Regents of the University of Michigan to investigate co-targeting NSD1/2 paralogs in androgen receptor-driven...
- The University of Queensland in Australia was awarded a $506,785 Project Grant from the U.S. Defense Health Agency's Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2025, supports the university's research to predict early-stage melanoma patients at high risk of recurrence through multiomics profiling. This biomedical research aims to transform healthcare for military service members, veterans, and the broader public by developing innovative...
- This federal Project Grant award, valued at $155,500.00 and provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is for the University of Wisconsin System to develop a model to study tumor-normal cell interaction in vitro for high-throughput drug screening. The research aims to transform healthcare for military service members and the broader public through innovative biomedical investigations. The one-year project will run from...
- The Defense Health Agency has awarded a $1,674,999.00 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). The grant is for the "PERTURBOMICS IDENTIFICATION OF CRITICAL GENETIC TARGETS IN NK CELLS FOR BREAST CANCER THERAPY" project, which will be conducted from September 1, 2023 to August 31, 2026. The funding will support basic, applied, and advanced biomedical research to transform healthcare for service members and the public...